102 related articles for article (PubMed ID: 2175057)
1. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity.
Yoshida M; Kozaki M; Ioya N; Kaji N; Tamaki T; Hiraishi S; Ishii H; Kazama M; Fukutomi K; Nagasawa T
Transplantation; 1990 Dec; 50(6):1066-9. PubMed ID: 2175057
[No Abstract] [Full Text] [Related]
2. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
[No Abstract] [Full Text] [Related]
3. Cyclosporine nephrotoxicity can be minimized by careful monitoring of whole blood trough levels.
Uchida K; Nakanisi N; Yamada N; Tominaga Y; Orihara A; Kondo T; Morimoto T; Morozumi K; Kano T; Takagi H
Dev Toxicol Environ Sci; 1986; 14():163-6. PubMed ID: 3549249
[No Abstract] [Full Text] [Related]
4. Cyclosporine-associated nephrotoxicity is not intractable.
Loertscher R
Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
[No Abstract] [Full Text] [Related]
5. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal transplants peripheral T cell subset counts.
Shen SY; Weir MR; Revie DR; Dagher FJ; Bentley FR; Chretien PB
Transplant Proc; 1987 Feb; 19(1 Pt 2):1776-9. PubMed ID: 2950634
[No Abstract] [Full Text] [Related]
7. Morphologic diagnosis of cyclosporine nephrotoxicity.
Mihatsch MJ; Thiel G; Ryffel B
Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
[No Abstract] [Full Text] [Related]
8. Cyclosporine or rejection enhance secretion of von Willebrand factor in renal transplantation.
Yussim A; Boksenboim G; Ben-Bassat M; Shmueli D; Lustig S; Bar Nathan N; Shaharabani E; Nakache R; Or H; Shapira Z
Transplant Proc; 1994 Aug; 26(4):2032-3. PubMed ID: 8066661
[No Abstract] [Full Text] [Related]
9. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
[No Abstract] [Full Text] [Related]
10. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
[No Abstract] [Full Text] [Related]
11. Expression of class II antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity.
Toma H; Tanabe K; Oba S; Horita S; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1987 Oct; 19(5):3719-20. PubMed ID: 3313898
[No Abstract] [Full Text] [Related]
12. Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantation.
Pichlmayr R; Wonigeit K; Ringe B; Block T; Raab R; Heigel B; Neuhaus P
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():947-60. PubMed ID: 3887390
[No Abstract] [Full Text] [Related]
13. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiology of circulation and distribution of thrombomodulin and von Willebrand factor in the brain].
Maruyama I; Okada A; Sinmyozu K
Rinsho Ketsueki; 1987 Jul; 28(7):1102-9. PubMed ID: 2826844
[No Abstract] [Full Text] [Related]
15. Conversion from cyclosporine to azathioprine in renal graft recipients.
MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
[TBL] [Abstract][Full Text] [Related]
16. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
[TBL] [Abstract][Full Text] [Related]
17. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
[No Abstract] [Full Text] [Related]
18. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
Diethelm AG
Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
[TBL] [Abstract][Full Text] [Related]
19. [Values of soluble thrombomodulin and von Willebrand factor judging reject reaction in liver transplantation].
Wen CG; Luo SK; He XS; Li J; Liu M; Zou WY; Peng AH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):295-7. PubMed ID: 12773246
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
Zannier A; Mutin M; Touraine JL; Traeger J
Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
